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In 1983, Steeper and Rosai described aggressive angio-
myxoma, primarily in the female pelvis and perineum,
as a distinctive variant of myxoid tumors with prominent
vascular component [1]. The tumor occurs predominantly
in the premenopausal female. We present a case of aggres-
sive angiomyxoma of the pelvis that coexisted with a huge
uterine myoma. After surgical resection, the patient was
followed-up in our outpatient department; if local recurrence
occurs, she will be treated with gonadotropin releasing
hormone (GnRH) agonist. A review of the literature is also
outlined.
CASE REPORT
A 39-year-old unmarried, nulliparous woman presented
with a history of nonspecific abdominal symptoms and a
right lower abdominal mass for 2 weeks. She came to our
gynecologic clinic for help. Abdominal sonography showed
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a solid mass with heteroechogenicity in the pelvic cavity.
Abdominal computed tomography (CT) showed a huge
cystic mass in the pelvis and uterine myoma (Figure 1).
Magnetic resonance imaging (MRI) also revealed a huge
soft tissue mass (18.5 × 7.8 × 11 cm) in the pelvic cavity,
which showed low signal intensity on T1-weighted MRI,
high signal on T2-weighted MRI with heterogeneous
enhancement after contrast administration (Figure 2). Some
foci showed strong enhancement within the mass. Uterine
myoma was also found. The diagnosis of retroperitoneal
liposarcoma or right ovary cystadenocarcinoma was favored
by our radiologist and biopsy was recommended. After
discussion with the patient, we decided to perform radical
tumor excision due to high malignant potency.
During exploratory laparotomy, a huge teardrop-shaped
mass was found in the pelvis, with invasion of the levator
ani. Extended tumor excision and myomectomy were
performed smoothly. Histologic examination of the
specimen showed a myxoid tumor with sparse infiltrates
of polymorphic cells clustering around blood vessels.
Immunohistochemical studies showed strong staining for
estrogen and progesterone receptors (Figure 3). Staining for
desmin and vimentin was intermediate, and staining for
S-100 protein was negative. The histologic diagnosis was
aggressive angiomyxoma.
© 2006 Elsevier. All rights reserved.
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After the operation, no stool or urine incontinence was
noted. The patient recovered well and returned to normal
daily activity. Pelvic CT (Figure 4) was performed in our
outpatient department after 6 months, and revealed no
evidence of local recurrence. If local recurrence does occur,
adjuvant hormone therapy with GnRH agonist will be given.
DISCUSSION
Aggressive angiomyxoma is a mesenchymal tumor that
affects women in > 90% of cases [2,3]. The tumor, which is
composed of scattered spindle cells and abundant medium-
sized vessels embedded in a myxoid matrix [1], arises from
connective tissues of the perineum or lower pelvis, but
rarely arises directly from any pelvic or perineal viscus
[4,5]. The lesions are characterized by a predominantly
myxoid pattern, different modes of presentation and
locally infiltrative behavior with tendency for multiple
recurrences.
Two factors may contribute to the high rate of local
recurrence. First, the tumor is not diagnosed before initial
surgery, and the extent of the tumor is frequently not per-
ceived. Second, the strategic location of the tumor around
Figure 4. Pelvic computed tomography 6 months after operation shows
no evidence of recurrence.
Figure 3. Immunohistochemical stains show that the tumor cells are
immunoreactive for progesterone and estrogen receptors, vimentin and
desmin.
Figure 1. Pelvic computed tomography with contrast enhancement
shows a huge soft tissue mass (arrow) with a swirled appearance,
occupying the hemi-pelvis and compressing the bladder.
Figure 2. Magnetic resonance imaging T2-weighted image shows a
teardrop-shaped mass (star) in the pelvis with heterogeneous enhancement.
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the urethra, vagina, and sphincter, and the rectum — with
extension above and below the pelvic diaphragm — makes
complete resection difficult and does not lend itself to ei-
ther abdominal or perineal surgical approaches alone. For
these reasons, most recurrences are likely to be related to
inadequate resection and residual tumor [6].
Imaging studies of these tumors are important to
determine the extent and optimal surgical approach.
Outwater et al found that the characteristics of angiomyxoma
has some variation on CT and MRI [7]. On CT, the tumor has
a well-defined margin and attenuation less than that of
muscle. On T2-weighted MRI, the tumor has high signal
intensity. The attenuation on CT and high signal intensity
on MRI are likely to be related to the loose myxoid matrix
and high water content of angiomyxoma [7]. Similarly, we
also found this tumor to have a swirled appearance on
enhanced CT (Figure 1). CT and MRI can accurately reveal
whether a tumor transverses the pelvic diaphragm. This
determination is critical to choose a surgical approach:
perineal or abdominal or both.
The tumor occurs predominantly in the premenopausal
female, suggesting that estrogen may stimulate its growth.
This concept is supported by a previous case report of
rapid growth of an angiomyxoma during pregnancy [8], a
state of increased estrogen and progesterone production.
The success of adjuvant therapy with a GnRH agonist
following complete surgical excision of an angiomyxoma
[9] gave us another choice if local recurrence should occur.
The patient’s aggressive angiomyxoma is clearly a dramatic
example of an estrogen and progesterone receptor-positive
tumor. Uterine myoma existing in this nulliparous female
also indicates hormonal imbalance. Therefore, follow-up
for local recurrence was mandatory for this patient, and
adjuvant GnRH agonist will be given if local recurrence
should occur.
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